Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

March 1, 2020; Volume 61,Issue 3

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 10A;

Discussions with Leaders

  • You have access
    A Conversation Between David Collingridge and Henryk Barthel
    David Collingridge and Henryk Barthel
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 307-310; DOI: https://doi.org/10.2967/jnumed.120.243311

The State of the Art

  • You have access
    Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine
    Lilja B. Solnes, Rudolf A. Werner, Krystyna M. Jones, Mohammad S. Sadaghiani, Christopher R. Bailey, Constantin Lapa, Martin G. Pomper and Steven P. Rowe
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 311-318; DOI: https://doi.org/10.2967/jnumed.118.220665

Continuing Education

  • You have access
    Molecular Imaging of Cardiovascular Device Infection: Targeting the Bacteria or the Host–Pathogen Immune Response?
    Wengen Chen and Vasken Dilsizian
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 319-326; DOI: https://doi.org/10.2967/jnumed.119.228304

Oncology

  • Clinical

    • You have access
      Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer
      Jia Wu, Michael F. Gensheimer, Nasha Zhang, Meiying Guo, Rachel Liang, Carrie Zhang, Nancy Fischbein, Erqi L. Pollom, Beth Beadle, Quynh-Thu Le and Ruijiang Li
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 327-336; DOI: https://doi.org/10.2967/jnumed.119.230037
    • You have access
      18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies
      Matthew S. Davenport, Jeffrey S. Montgomery, Lakshmi Priya Kunju, Javed Siddiqui, Prasad R. Shankar, Thekkelnaycke Rajendiran, Xia Shao, Eunjee Lee, Brian Denton, Christine Barnett and Morand Piert
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 337-343; DOI: https://doi.org/10.2967/jnumed.119.225789
    • You have access
      Observer Agreement and Accuracy of 18F-Sodium Fluoride PET/CT in the Diagnosis of Bone Metastases in Prostate Cancer
      Helle D. Zacho, Randi F. Fonager, Julie B. Nielsen, Christian Haarmark, Helle W. Hendel, Martin B. Johansen, Jesper C. Mortensen and Lars J. Petersen
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 344-349; DOI: https://doi.org/10.2967/jnumed.119.232686
    • You have access
      First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver
      Alexandre Ponti, Alban Denys, Antonia Digklia, Niklaus Schaefer, Arnaud Hocquelet, Jean-François Knebel, Olivier Michielin, Clarisse Dromain and Rafael Duran
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 350-356; DOI: https://doi.org/10.2967/jnumed.119.230870
    • You have access
      Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer
      Milan Grkovski, Reema Goel, Simone Krebs, Kevin D. Staton, James J. Harding, Ingo K. Mellinghoff, John L. Humm and Mark P.S. Dunphy
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 357-366; DOI: https://doi.org/10.2967/jnumed.119.229740
    • You have access
      Diagnosis, Treatment Response, and Prognosis: The Role of 18F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with 123I-mIBG Scan: The First Prospective Study
      Arnoldo Piccardo, Giovanni Morana, Matteo Puntoni, Sara Campora, Stefania Sorrentino, Pietro Zucchetta, Martina Ugolini, Massimo Conte, Angelina Cistaro, Giulia Ferrarazzo, Marco Pescetto, Marco Lattuada, Gianluca Bottoni, Alberto Garaventa, Luca Giovanella and Egesta Lopci
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 367-374; DOI: https://doi.org/10.2967/jnumed.119.232553

Theranostics

  • Clinical

    • SPECIAL CONTRIBUTION

      • You have access
        Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
        Kevin J. Donohoe, Jennifer Aloff, Anca M. Avram, K.G. Bennet, Luca Giovanella, Bennett Greenspan, Seza Gulec, Aamna Hassan, Richard T. Kloos, Carmen C. Solórzano, Brendan C. Stack, Mark Tulchinsky, Robert Michael Tuttle, Douglas Van Nostrand and Jason A. Wexler
        Journal of Nuclear Medicine March 1, 2020, 61 (3) 375-396; DOI: https://doi.org/10.2967/jnumed.119.240945
    • You have access
      Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer
      Di Wu, Cristiane J. Gomes Lima, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky and Douglas Van Nostrand
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 397-404; DOI: https://doi.org/10.2967/jnumed.119.230730
    • You have access
      Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines
      Kelsey L. Pomykala, Johannes Czernin, Tristan R. Grogan, Wesley R. Armstrong, John Williams and Jeremie Calais
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 405-411; DOI: https://doi.org/10.2967/jnumed.119.230318

Infectious Disease

  • Clinical

    • You have access
      18F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis
      Ismaheel O. Lawal, Bernard P. Fourie, Matsontso Mathebula, Ingrid Moagi, Thabo Lengana, Nontando Moeketsi, Maphoshane Nchabeleng, Mark Hatherill and Mike M. Sathekge
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 412-417; DOI: https://doi.org/10.2967/jnumed.119.233783

Neurology

  • Clinical

    • FEATURED CLINICAL INVESTIGATION ARTICLE

      • You have access
        18F-FDG PET Imaging of the Inferior Colliculus in Asymmetric Hearing Loss
        Iva Speck, Susan Arndt, Johannes Thurow, Ganna Blazhenets, Antje Aschendorff, Philipp T. Meyer and Lars Frings
        Journal of Nuclear Medicine March 1, 2020, 61 (3) 418-422; DOI: https://doi.org/10.2967/jnumed.119.231407
    • You have access
      High Availability of the α7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using 18F-ASEM PET
      Jennifer M. Coughlin, Leah H. Rubin, Yong Du, Steven P. Rowe, Jeffrey L. Crawford, Hailey B. Rosenthal, Sarah M. Frey, Erica S. Marshall, Laura K. Shinehouse, Allen Chen, Caroline L. Speck, Yuchuan Wang, Wojciech G. Lesniak, Il Minn, Arnold Bakker, Vidyulata Kamath, Gwenn S. Smith, Marilyn S. Albert, Babak Behnam Azad, Robert F. Dannals, Andrew Horti, Dean F. Wong and Martin G. Pomper
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 423-426; DOI: https://doi.org/10.2967/jnumed.119.230979

Molecular Imaging

  • Basic

    • You have access
      Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia
      John M. Floberg, Lingjue Wang, Nilantha Bandara, Ramachandran Rashmi, Cedric Mpoy, Joel R. Garbow, Buck E. Rogers, Gary J. Patti and Julie K. Schwarz
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 427-432; DOI: https://doi.org/10.2967/jnumed.119.230805

Immunotherapy

  • Basic

    • BRIEF COMMUNICATION

      • Open Access
        An 89Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
        Christian A. Mason, Susanne Kossatz, Lukas M. Carter, Giacomo Pirovano, Christian Brand, Navjot Guru, Carlos Pérez-Medina, Jason S. Lewis, Willem J.M. Mulder and Thomas Reiner
        Journal of Nuclear Medicine March 1, 2020, 61 (3) 433-436; DOI: https://doi.org/10.2967/jnumed.119.230466

Radiochemistry

  • Basic

    • You have access
      Noninvasive PET Imaging of CDK4/6 Activation in Breast Cancer
      Nicholas Ramos, Jairo Baquero-Buitrago, Zakia Ben Youss Gironda, Youssef Zaim Wadghiri, Thomas Reiner, Fernando E. Boada and Giuseppe Carlucci
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 437-442; DOI: https://doi.org/10.2967/jnumed.119.232603
    • You have access
      Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonistic and Antagonistic Constructs
      Wenting Zhang, Wei Fan, Brendan M. Ottemann, Sameer Alshehri and Jered C. Garrison
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 443-450; DOI: https://doi.org/10.2967/jnumed.119.231282

Physics and Instrumentation

  • Basic

    • INVITED PERSPECTIVE

      • You have access
        Total-Body PET Imaging for up to 30 Days After Injection of 89Zr-Labeled Antibodies
        Zachary T. Rosenkrans and Weibo Cai
        Journal of Nuclear Medicine March 1, 2020, 61 (3) 451-452; DOI: https://doi.org/10.2967/jnumed.119.236166
    • FEATURED ARTICLE OF THE MONTH

      • You have access
        Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection
        Eric Berg, Herman Gill, Jan Marik, Annie Ogasawara, Simon Williams, Guus van Dongen, Daniëlle Vugts, Simon R. Cherry and Alice F. Tarantal
        Journal of Nuclear Medicine March 1, 2020, 61 (3) 453-460; DOI: https://doi.org/10.2967/jnumed.119.230961
    • Open Access
      Standardization of Preclinical PET/CT Imaging to Improve Quantitative Accuracy, Precision, and Reproducibility: A Multicenter Study
      Wendy McDougald, Christian Vanhove, Adrienne Lehnert, Barbara Lewellen, John Wright, Marco Mingarelli, Carlos Alcaide Corral, Jurgen E. Schneider, Sven Plein, David E. Newby, Andy Welch, Robert Miyaoka, Stefaan Vandenberghe and Adriana Alexandre S. Tavares
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 461-468; DOI: https://doi.org/10.2967/jnumed.119.231308
    • You have access
      Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts
      Elisabeth Pfaehler, Joyce van Sluis, Bram B.J. Merema, Peter van Ooijen, Ralph C.M. Berendsen, Floris H.P. van Velden and Ronald Boellaard
      Journal of Nuclear Medicine March 1, 2020, 61 (3) 469-476; DOI: https://doi.org/10.2967/jnumed.119.229724

SNMMI Newsline

  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 11N-22N;
  • You have access
    Appropriate Use Criteria for Gastrointestinal Transit Scintigraphy
    Alan H. Maurer, Thomas Abell, Paige Bennett, Jesus R. Diaz, Lucinda A. Harris, William Hasler, Andrei Iagaru, Kenneth L. Koch, Richard W. McCallum, Henry P. Parkman, Satish S.C. Rao and Mark Tulchinsky
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 11N-17N;
  • You have access
    Marta Cremonesi, PhD, 2020 Loevinger–Berman Award Recipient
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 17N;
  • You have access
    Improving Nuclear Medicine Practice with UEMS/EBNM Committees
    Siroos Mirzaei, Roland Hustinx, John O. Prior, Zehra Ozcan, Ariane Boubaker and Mohsen Farsad; for the European Union of Medical Specialists and European Board for Nuclear Medicine
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 18N-20N;
  • You have access
    SNMMI Leadership Update: The Nuclear Medicine Community: From 1970s Cookbook to 2020 Global Influence
    Vasken Dilsizian
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 19N-20N;
  • You have access
    FDA Compounding Quality Center of Excellence
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 21N-22N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 61 (3)
Journal of Nuclear Medicine
Vol. 61, Issue 3
March 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection
  • 18F-FDG PET Imaging of the Inferior Colliculus in Asymmetric Hearing Loss
  • Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine
  • Molecular Imaging of Cardiovascular Device Infection: Targeting the Bacteria or the Host–Pathogen Immune Response?
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Continuing Education
  • Oncology
    • Clinical
  • Theranostics
    • Clinical
      • SPECIAL CONTRIBUTION
  • Infectious Disease
    • Clinical
  • Neurology
    • Clinical
      • FEATURED CLINICAL INVESTIGATION ARTICLE
  • Molecular Imaging
    • Basic
  • Immunotherapy
    • Basic
      • BRIEF COMMUNICATION
  • Radiochemistry
    • Basic
  • Physics and Instrumentation
    • Basic
      • INVITED PERSPECTIVE
      • FEATURED ARTICLE OF THE MONTH
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire